Report Categories
View AllRecent Articles
View All
MATX Matson posts narrow Q4 2025 earnings beat dips 05 percent amid muted investor reaction
Dominion Energy D Strong Offshore Wind Execution and Expanded State Storage Mandate Boost LongTerm Regulated Growth Visibility
BAA Boeing PrefA Series A mandatory convertible preferred stock reports quarterly results amid market volatility
Grayscale Ethereum Staking ETF ETHE Assessing Upside Potential Amid Crypto Rally Regulatory Headwinds and Geopolitical Volatility
LSB Industries LXU Q1 2026 Earnings Beat Revenue NA EPS 027
Nvidia Posts 85 Revenue Surge Yet Keeps China Out of Forward Guidance
Biologics ADMA Slides 088 as Selling Pressure Mounts 20260521
Runway RWAYI Unchanged at 2444 RangeBound Trading 20260520
Rajnandini Fashion India IPO Sees Strong Day One Subscription Led by Institutional Investors
Chinas Rare Earth Dominance Reshapes Global Supply Chain Dynamics
US Iran Signal Progress on Middle East Peace But Remain Divided Over Uranium Enrichment and Strait of Hormuz Tolls
Data Training Imbalances May Skew AIGenerated Mental Health Advice Raising Reliability Concerns
Military Tech Firms Aim to Reshape American Defense but Hurdles Remain
Bitcoin Slides Below 77000 as US Strikes on Iran Intensify Geopolitical Risk and ETF Outflows Mount
Energy Services of America Corporation ESOA Q1 2026 Earnings EPS Surges Past Estimates by 743 Despite Stock Pullback
BKKT Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Revenue Uncertainty
Heritage Financial Corporation HFWA Q1 2026 Earnings EPS Beat on Solid Core Performance
ELTX Q1 2026 Earnings EPS Miss as ClinicalStage Biotech Advances Pipeline Without Revenue
GLMD Q4 2025 Earnings WiderThanExpected Loss as Galmed Continues Clinical Development
iQIYI Q1 2026 Earnings EPS Misses Estimates as Profitability Challenges Persist
Nuveen Real Asset Income Fund JRI Holds Steady Near Key Levels
Levi Strauss LEVI Shares Surge 291 as Denim Giant Gains Momentum
Karyopharm Therapeutics KPTI Posts Gains Bounces from Support Tests Key Resistance
Perimeter Acquisition Corp I Warrant PMTRW Holds Steady at 077 Amid Low Activity
Novartis NVS Holds Gains Near 151 as Pharmaceutical Sector Shows Stability